Skip to main content

Corient Private Wealth LLC

Position in NVO — Novo Nordisk A S

CIK 1948780 MIAMI, FL

Position in NVO

as of Jun 30, 2026 · filed Aug 27, 2026
Position Value
$31,133,626
+$6,400,913 QoQ
Shares Held
649,429
-3.5% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#72
of 1,348 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 49% Shared 1% None 50%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Corient Private Wealth LLC holds $2,580,155,060 across 16 Drug Manufacturers - General names. NVO ranks #9 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVO

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $31,133,626 649,429
2026-03-31 $24,732,713 672,999
2025-12-31 $36,091,880 709,353
2025-09-30 $40,401,158 728,080
2025-06-30 $72,567,972 1,051,405
2025-03-31 $78,079,584 1,124,418
2024-12-31 $109,822,592 1,276,710
2024-09-30 $166,409,135 1,397,574
2024-06-30 $198,350,218 1,389,591
2024-03-31 $167,047,372 1,300,992
2023-12-31 $129,127,840 1,248,215
2023-09-30 $76,053,849 836,308
2023-06-30 $65,655,401 405,706
2023-03-31 $50,346,325 316,365
2022-12-31 $9,327,632 68,920